Most people with COVID-19 have mild illness and recover at home with rest and over-the-counter medications. For those at higher risk of severe disease, prescription antiviral treatments can reduce the chance of hospitalization and death by over 40% when started within five days of symptoms. The right treatment depends on your symptoms, your risk factors, and how quickly you act.
Mild Symptoms: Managing COVID-19 at Home
If you’re otherwise healthy and your symptoms feel like a bad cold or flu, home care is the main treatment. Acetaminophen and ibuprofen both help with fever, body aches, and headaches. Stay hydrated, rest, and monitor your symptoms. Most people start feeling better within a week, though fatigue and cough can linger longer.
The key thing to watch is your breathing. If you notice shortness of breath, persistent chest pain or pressure, or confusion, those are signs the infection is moving beyond mild territory. An oxygen saturation below 94% on a pulse oximeter (widely available at pharmacies) is the clinical threshold that separates mild from severe COVID-19.
Prescription Antivirals for High-Risk Patients
Two oral antiviral medications can prevent mild COVID-19 from becoming serious illness. Both must be started within five days of your first symptoms to work, so time matters.
The first and most effective option is nirmatrelvir/ritonavir (Paxlovid). It’s a five-day, twice-daily pill course approved for adults and for adolescents over 12 who weigh at least 88 pounds. In a large Cleveland Clinic study, it lowered the risk of death by 84% and reduced combined hospitalization and death by over 40% compared to no treatment. You’re eligible if you have one or more risk factors for severe COVID-19, which includes conditions like obesity, diabetes, heart disease, lung disease, being immunocompromised, or being over 65.
The second option, molnupiravir (Lagevrio), works similarly but is slightly less potent, reducing death risk by about 77%. It’s typically considered when Paxlovid isn’t suitable for a given patient.
The Five-Day Window
Both drugs need to be started within five days of symptom onset. Their effectiveness drops the longer you wait. If you test positive and have risk factors, contact a healthcare provider that same day. Many telehealth services and pharmacies can prescribe antivirals quickly, sometimes within hours of a positive test.
Drug Interactions With Paxlovid
Paxlovid interacts with a long list of common medications because one of its components (ritonavir) affects how your liver processes other drugs. This is the most common reason people can’t take it, and it’s worth knowing about before you need it.
Several categories of medication are incompatible with Paxlovid. These include certain heart rhythm drugs (like amiodarone and flecainide), some cholesterol-lowering statins (lovastatin and simvastatin, though these can be temporarily paused), certain sedatives, some seizure medications like carbamazepine and phenytoin, and the herbal supplement St. John’s Wort. People taking immunosuppressants, certain blood pressure medications, or specific migraine treatments also need careful evaluation.
If you take medications regularly, keep an updated list handy. When you call about a positive COVID test, your provider will cross-check your medications against the interaction list. In many cases, a short pause on a conflicting medication makes Paxlovid possible. In others, molnupiravir or a different treatment approach may be the better choice.
IV Treatment for Higher-Risk Outpatients
Remdesivir (Veklury) is an antiviral given by IV infusion. For non-hospitalized patients at high risk of progression, the treatment is a three-day course that must begin within seven days of symptom onset. It requires visiting an infusion center each day, which makes it less convenient than oral pills, but it’s an important option for patients who can’t take Paxlovid or molnupiravir due to drug interactions or other reasons.
Treatment for Severe COVID-19 in the Hospital
When COVID-19 causes significant breathing problems, treatment shifts to hospital-based therapies. The cornerstone for patients needing supplemental oxygen is a corticosteroid called dexamethasone, which calms the overactive immune response that damages the lungs. It’s used when oxygen saturation drops to 94% or below on room air.
Remdesivir is also used in the hospital setting, typically for five days in patients who don’t need a ventilator, and up to ten days for those who do. For patients whose condition worsens despite steroids and oxygen, doctors may add immune-modulating medications that target specific inflammatory pathways. These are reserved for the sickest patients and are used alongside corticosteroids, not instead of them.
Monoclonal antibody treatments, which were widely used earlier in the pandemic, are no longer effective against current circulating variants. The virus has mutated enough that previously authorized antibody therapies don’t neutralize it. Researchers are developing new “bispecific” antibodies designed to work against all known variants, but these aren’t yet available outside of clinical trials.
COVID-19 Rebound After Treatment
Some people experience a return of symptoms a few days after finishing antiviral treatment, commonly called “rebound.” This got significant attention with Paxlovid, but the data tell a more nuanced story. A large CDC-analyzed study found rebound rates of about 6.6% in Paxlovid-treated patients, 4.8% in molnupiravir-treated patients, and 4.5% in untreated patients. The differences were not statistically significant, meaning rebound happens at similar rates whether or not you take antivirals.
Some smaller studies have reported higher rebound rates of 10% to 14% among treated patients, but even accounting for those numbers, the CDC and NIH are clear: the possibility of rebound should not discourage you from taking antivirals when they’re indicated. The drugs’ ability to prevent hospitalization and death far outweighs the inconvenience of a few extra days of mild symptoms. If rebound happens, it’s typically mild and resolves on its own without additional treatment.
Acting Quickly Makes the Biggest Difference
The single most important factor in COVID-19 treatment is speed. Every antiviral option works best when started early. If you test positive and you’re over 65, immunocompromised, or living with a chronic condition like diabetes, heart disease, or lung disease, getting a prescription within the first day or two of symptoms gives you the strongest protection. Keep rapid tests on hand, know your risk factors, and have a plan for reaching a provider quickly. The treatments exist and they work, but only if you use them in time.